Finance

Beta
Lists
PASG:NASDAQ
Passage Bio Inc
$5.13
-7.90%
(-0.44) 1D
Jun 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PASG...
Open
$5.46
High
$5.89
Low
$4.92
Mkt. cap
16.46M
Avg. vol.
58.10K
Volume
71.96K
52-wk high
$20.00
52-wk low
$3.94
EPS
-$11.84
Beta
1.41
Shares outstanding
3.21M
No. of employees
24
Open
$5.46
High
$5.89
Low
$4.92
Mkt. cap
16.46M
Avg. vol.
58.10K
Volume
71.96K
52-wk high
$20.00
52-wk low
$3.94
EPS
-$11.84
Beta
1.41
Shares outstanding
3.21M
No. of employees
24
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to PASG in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PASG in the last 3 months.
Highest
Current $5.13
$23.00 (+348.34%)
Average
$11.75 (+129.04%)
Lowest
$7.00 (+36.45%)
News stories
From sources across the web
About Passage Bio Inc
CEO-
Employees24
Founded2017
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$2.36 / -$3.01
+21.66%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.81M
4.31M
5.42M
4.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.52M
4.35M
4.92M
4.79M
Operating expense
10.33M
8.66M
10.34M
8.25M
Total operating expenses
10.33M
8.66M
10.34M
8.25M
Operating income
-10.33M
-8.66M
-10.34M
-8.25M
Other non operating income
-451.00K
406.00K
365.00K
688.00K
EBT including unusual items
-9.38M
-7.75M
-12.98M
-7.56M
EBT excluding unusual items
-9.38M
-7.75M
-9.48M
-7.56M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-633.00K
Net income
-9.38M
-7.75M
-12.98M
-7.56M
Net profit margin
-
-
-
-
Earnings per share
-2.96
-2.44
-4.09
-2.36
Interest and investment income
1.40M
500.00K
500.00K
-
Interest expense
-
-
-
-
Net interest expenses
1.40M
500.00K
500.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.16M
-8.47M
-10.16M
-8.12M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more